DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Cameron D, Brown J, Dent R et al.
Primary results of BEATRICE, a randomized phase III trial evaluating adjuvant
bevacizumab-containing therapy in triple negative breast cancer.
Cancer Res 2012;
72 (Suppl. 24) 108s
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.